MENU

LIANY Stock LIANY is expected to report earnings to rise+13.64% to -19 cents per share on March 26

A.I.dvisor
at Tickeron.com
Loading...
LIANY - LianBio
LianBio Earnings Graph
Q4'23
Est.
$-0.19
Q3'23
Beat
by $0.11
Q2'23
Beat
by $0.09
Q1'23
Beat
by $0.07
Q4'22
Beat
by $0.10
The last earnings report on September 30 showed earnings per share of -22 cents, beating the estimate of -33 cents. P/B Ratio (0.104) is normal, around the industry mean (13.470). P/E Ratio (0.000) is within average values for comparable stocks, (65.620). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.798). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (238.014). With 12.06K shares outstanding, the current market capitalization sits at 21.12M.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
103 Carnegie Center Drive
Phone
+1 609 486-2308
Employees
52
Web
https://www.lianbio.com